Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announces that it has acquired Prolaio, a clinical intelligence company advancing cardiology research and care with real-world patient data and insights. In addition to its FDA-cleared patient monitoring software, Prolaio has assembled one of the largest curated CV clinical data sets in the industry and developed world-leading analytics with an aim to predict and help clinicians proactively treat heart-related health challenges. Through this strategic business combination, Kardigan gains access to Prolaio’s industry-leading CV data collection and analytics platform.
Read the full article: Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform //
Source: https://www.businesswire.com/news/home/20250327713680/en/Kardigan-Acquires-Prolaio-to-Create-a-Pioneering-Heart-Health-Company-with-One-of-a-Kind-Integrated-Cardiovascular-Data-and-Therapeutics-Platform